NasdaqGS - Delayed Quote • USD
ICU Medical, Inc. (ICUI)
At close: May 17 at 4:00 PM EDT
After hours: May 17 at 4:20 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 4 | 4 | 5 | 5 |
Avg. Estimate | 1 | 1.32 | 4.83 | 6.56 |
Low Estimate | 0.88 | 1.27 | 4.64 | 6.2 |
High Estimate | 1.07 | 1.39 | 4.96 | 7.12 |
Year Ago EPS | 1.88 | 1.57 | 6.86 | 4.83 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 4 | 4 | 5 | 5 |
Avg. Estimate | 556.72M | 570.75M | 2.28B | 2.36B |
Low Estimate | 554.5M | 563M | 2.27B | 2.32B |
High Estimate | 558.8M | 576.2M | 2.28B | 2.39B |
Year Ago Sales | -- | 546.62M | 2.21B | 2.28B |
Sales Growth (year/est) | -- | 4.40% | 2.90% | 3.90% |
Earnings History
CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
---|---|---|---|---|
EPS Est. | 1.6 | 1.38 | 1.19 | 0.82 |
EPS Actual | 1.88 | 1.57 | 1.57 | 0.96 |
Difference | 0.28 | 0.19 | 0.38 | 0.14 |
Surprise % | 17.50% | 13.80% | 31.90% | 17.10% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 1 | 1.32 | 4.83 | 6.56 |
7 Days Ago | 1 | 1.32 | 4.83 | 6.56 |
30 Days Ago | 1 | 1.33 | 4.73 | 6.78 |
60 Days Ago | 1 | 1.33 | 4.73 | 6.78 |
90 Days Ago | 0.9 | 1.11 | 5.18 | 7.31 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | 2 | 2 | 4 | 1 |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | ICUI | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | -46.80% | -- | -- | 8.00% |
Next Qtr. | -15.90% | -- | -- | 12.40% |
Current Year | -29.60% | -- | -- | 5.60% |
Next Year | 35.80% | -- | -- | 13.00% |
Next 5 Years (per annum) | 16.00% | -- | -- | 11.14% |
Past 5 Years (per annum) | -6.98% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Maintains | Keybanc: Overweight to Overweight | 2/28/2024 |
Initiated | Keybanc: Overweight | 2/6/2024 |
Initiated | CL King: Buy | 12/14/2023 |
Maintains | Keybanc: Overweight | 5/9/2023 |
Downgrade | Raymond James: Outperform to Market Perform | 11/8/2022 |
Maintains | Raymond James: Outperform | 8/9/2022 |
Related Tickers
MMSI Merit Medical Systems, Inc.
81.89
-0.45%
NVST Envista Holdings Corporation
18.53
-3.14%
HAE Haemonetics Corporation
95.73
+0.98%
TFX Teleflex Incorporated
217.64
-0.43%
RGEN Repligen Corporation
171.94
+0.53%
WST West Pharmaceutical Services, Inc.
355.64
+0.43%
CZMWY Carl Zeiss Meditec AG
103.78
-1.36%
ATRI Atrion Corporation
465.25
+2.06%
XRAY DENTSPLY SIRONA Inc.
28.28
-0.35%
COO The Cooper Companies, Inc.
97.31
-0.60%